Cargando…

Re: Implication of low‐dose sacubitril/valsartan

Detalles Bibliográficos
Autores principales: Pandey, Amitabh C., Heywood, James Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943907/
https://www.ncbi.nlm.nih.gov/pubmed/33570218
http://dx.doi.org/10.1002/clc.23560
_version_ 1783662593724907520
author Pandey, Amitabh C.
Heywood, James Thomas
author_facet Pandey, Amitabh C.
Heywood, James Thomas
author_sort Pandey, Amitabh C.
collection PubMed
description
format Online
Article
Text
id pubmed-7943907
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wiley Periodicals, Inc.
record_format MEDLINE/PubMed
spelling pubmed-79439072021-03-16 Re: Implication of low‐dose sacubitril/valsartan Pandey, Amitabh C. Heywood, James Thomas Clin Cardiol Letters to the Editor Wiley Periodicals, Inc. 2021-02-11 /pmc/articles/PMC7943907/ /pubmed/33570218 http://dx.doi.org/10.1002/clc.23560 Text en © 2021 The Authors. Clinical Cardiology published by Wiley Periodicals LLC. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Pandey, Amitabh C.
Heywood, James Thomas
Re: Implication of low‐dose sacubitril/valsartan
title Re: Implication of low‐dose sacubitril/valsartan
title_full Re: Implication of low‐dose sacubitril/valsartan
title_fullStr Re: Implication of low‐dose sacubitril/valsartan
title_full_unstemmed Re: Implication of low‐dose sacubitril/valsartan
title_short Re: Implication of low‐dose sacubitril/valsartan
title_sort re: implication of low‐dose sacubitril/valsartan
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943907/
https://www.ncbi.nlm.nih.gov/pubmed/33570218
http://dx.doi.org/10.1002/clc.23560
work_keys_str_mv AT pandeyamitabhc reimplicationoflowdosesacubitrilvalsartan
AT heywoodjamesthomas reimplicationoflowdosesacubitrilvalsartan